1-10 of 10
Peter G. Maslak, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multiparameter Flow Cytometry For Detection Of Minimal Residual Disease In Multiple Myeloma After T-Cell Depleted Allogeneic Stem Cell Transplant

Satyajit Kosuri, MD, Katherine M Smith, BA, Deborah Kuk, MS, Sean M. Devlin, PhD, Peter G. Maslak, M.D., Sergio Giralt, MD, Guenther Koehne, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4647.
https://doi.org/10.1182/blood.V122.21.4647.4647
Published: 2013
Journal Articles

Chronic Myeloid Leukemia After Adjuvant Treatment For Breast Cancer: Is It Therapy Related?

Ashwin Kishtagari, MBBS, Isaac Alexander Bowman, MD, Martin S. Tallman, MD, Dan Douer, MD, Ellin Berman, MD, Peter G. Maslak, M.D., Renier J Brentjens, MD, PhD, Eytan M Stein, MD
Journal: Blood
Blood (2013) 122 (21): 2740.
https://doi.org/10.1182/blood.V122.21.2740.2740
Published: 2013
Journal Articles

Potential Clinical Impact of Inaccurate Automated Platelet Counts in the Setting of Severe Thrombocytopenia

Steven M. Marionneaux, MS, MT(ASCP), Peter G. Maslak, M.D., Nenita Francisco, MT, Virgil Chan, MT(ASCP), Justin Hanenberg, MT(ASCP), Jean Lynch, MT(ASCP), Josephine Rafael, MT(ASCP), Jingqiu Yao, MT, Conchita Chua, MT(ASCP)
Journal: Blood
Blood (2012) 120 (21): 3428.
https://doi.org/10.1182/blood.V120.21.3428.3428
Published: 2012
Journal Articles

Phase II Trial of WT1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR)

Todd L. Rosenblat, MD, Mark G. Frattini, MD, PhD, Suzanne M. Chanel, RN, Tao Dao, MD, PhD, Yvette Bernal, Joseph G. Jurcic, MD, Rhong Zhang, Pamela Simancek, Martin S Tallman, MD, David A. Scheinberg, MD, PhD, Peter G. Maslak, M.D.
Journal: Blood
Blood (2012) 120 (21): 3624.
https://doi.org/10.1182/blood.V120.21.3624.3624
Published: 2012
Journal Articles

Aerobic Glycolysis Predicts Outcome in Early Chronic Lymphocytic Leukemia.

Jeffrey R Gardner, MBA, Sean Devlin, PhD, Kristina Knapp, Francesco Bauli, MS, Nicole Lamanna, MD, Mark G. Frattini, MD, PhD, Renier J Brentjens, MD, PhD, Peter G. Maslak, M.D., Joseph G. Jurcic, MD, Mark Weiss, MD, David A. Scheinberg, MD, PhD, Mark Heaney, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2482.
https://doi.org/10.1182/blood.V120.21.2482.2482
Published: 2012
Journal Articles

High Dose Cytarabine and Mitoxantrone in Combination with Dasatinib As Active Induction Therapy in Adult Patients with Philadelphia Chromosome Positive (ph+) Acute Lymphoblastic Leukemia (ALL)

Nicole Lamanna, MD, Mark Weiss, MD, Ellin Berman, MD, Mark G. Frattini, MD, PhD, Mark Heaney, MD, PhD, Joseph G. Jurcic, MD, Todd L. Rosenblat, MD, Heather Landau, MD, Hanna Weissbrot, BA, Peter G. Maslak, M.D.
Journal: Blood
Blood (2012) 120 (21): 4293.
https://doi.org/10.1182/blood.V120.21.4293.4293
Published: 2012
Journal Articles

Elevated Mitochondrial Membrane Potential in CLL Cells Is Associated with a more aggressive Natural History

Jeffrey R Gardner, MBA, Kristina Knapp, Mark G. Frattini, MD, PhD, Nicole Lamanna, MD, Renier Brentjens, MD, PhD, Joseph G Jurcic, MD, Peter G. Maslak, M.D., Ellin Berman, MD, Mark Weiss, MD, David A. Scheinberg, MD, PhD, Mark Heaney, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1765.
https://doi.org/10.1182/blood.V118.21.1765.1765
Published: 2011
Journal Articles

Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 ( 225 Ac)-Lintuzumab (Anti-CD33; HuM195) in Acute Myeloid Leukemia (AML)

Joseph G. Jurcic, MD, Todd L. Rosenblat, MD, Michael R. McDevitt, PhD, Neeta Pandit-Taskar, MD, Jorge A. Carrasquillo, MD, Suzanne M. Chanel, RN, Kevin Zikaras, BS, Mark G. Frattini, MD, PhD, Peter G. Maslak, M.D., Dragan Cicic, MD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 768.
https://doi.org/10.1182/blood.V118.21.768.768
Published: 2011
Journal Articles

Translocation t(11;17) Is Not Always Associated with Acute Myeloid or Acute Promyelocytic Leukemia

Muhamed Baljevic, M.D., Suresh C. Jhanwar, PhD, Todd L. Rosenblat, MD, Peter G. Maslak, M.D., Dan Douer, M.D., Martin S. Tallman, MD
Journal: Blood
Blood (2011) 118 (21): 5044.
https://doi.org/10.1182/blood.V118.21.5044.5044
Published: 2011
Journal Articles

Influence of National Comprehensive Cancer Network (NCCN) Guidelines on Clinical Practice in Patients with Chronic Myelogenous Leukemia (CML) Treated At a Single Academic Medical Center

Ellin Berman, MD, Cyrus V. Hedvat, MD, PhD, Joseph G. Jurcic, MD, Mark Heaney, MD, PhD, Peter G. Maslak, M.D., Renier Brentjens, MD, PhD, Nicole Lamanna, MD, Todd L. Rosenblat, MD, Mark G. Frattini, MD, PhD, Ann A Jakubowski, MD, PhD, Suresh Jhanwar, PhD
Journal: Blood
Blood (2011) 118 (21): 4433.
https://doi.org/10.1182/blood.V118.21.4433.4433
Published: 2011